You Position: Home > Paper

A primary study on high dose thymosine in the treatment of refractory rheumatic diseases

( views:151, downloads:12 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
Issue:
4
DOI:
10.3760/cma.j.issn.1008-6706.2002.04.003
Key Word:
胸腺肽;风湿病;难治性;治疗

Abstract: 目的了解大剂量胸腺肽对风湿性疾病的治疗价值.方法 12例难治性风湿病在常规治疗基础上加用大剂量胸腺肽治疗,每次160 mg,每周5次,3个月后改每周2次.随访1年以上,观察临床情况、TNF活性及IL-2、ESR和CRP水平的变化.结果所有病人临床均获得缓解,全部病例TNF活性恢复正常,71.4%病例IL-2水平及75%病例ESR、CRP恢复正常.结论大剂量胸腺肽可作为慢作用抗风湿药的替代或补充.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn